ECONOMIC BURDEN OF INVASIVE PNEUMOCOCCAL DISEASES IN URBAN CHINA
Author(s)
Liu G1, Zhu L2, Li D1, Chen DE1, Deng J1, Dong P3, Shi Q41Peking University, Beijing, China, 2Peking University, Beijing, Beijing, China, 3Pfizer, Beijing , China, 4Pfizer China, Shanghai, China
Presentation Documents
OBJECTIVES: To estimate direct medical cost and productivity lost for invasive pneumococcal diseases in child under 2 in urban China. METHODS: Six health status contained pneumococcal meningitis (inpatient), pneumococcal septicemia (inpatient), pneumonia (all-cause, inpatient), pneumonia (all-cause, outpatient), mild otitis media (all-cause,outpatient) and sever otitis media (all-cause, outpatient )were considered. Age-specific cost was collected from electronic patient records (2010) from 14 hospitals in 7 cities in China. 2 hospitals in each city was selected (1 Children’s Hospital, 1 Comprehensive Hospitals) and 7 field cities including Beijing, Guangzhou, Shenzhen, Wuhan, Xi’an, Chengdu and Shenyang were enrolled. Direct medical cost included registry fee, medications, and diagnostic tests fee, hospitalization expenditure. Cost of productivity lost were days for work absent of patient plus time consumed of infirmaries. In first part, weighted average method was used to calculate average direct medical cost. In second part, daily wage rate was applied to estimate cost of productivity lost. RESULTS: The average direct medical cost in all IPD cases (pneumococcal meningitis& pneumococcal septicemia) was 20,950 Yuan (95%CI: 4,489-101,003). Average 19 working days lost in patients’ relatives for caring and costs of productivity lost was 1934 Yuan (95%CI: 532-6,412) per patient. CONCLUSIONS: IPD has a serious impact on life quality of child under 2 in Chinese urban areas and it could lead to severe economic burden.
Conference/Value in Health Info
2012-09, ISPOR Asia Pacific 2012, Taipei, Taiwan
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PIN11
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)